ARCHIVES

Bayer’s HER-2/neu Blood Test Cleared By FDA For Marketing.

This article is from The Cancer Letter archive.

Vol. 26 No. 46 | December 15, 2000

Download PDF Visit The Full Archive

Related Articles

Randomization With Options Stimulates Sedmental Accrual

February 22, 1980

GAO Report: Taxol CRADA “Successful,” But Not Great Financial Deal.

June 27, 2003

Former NCI Lab Deputy Charged With Two Criminal Counts

January 17, 1992

NCI advisory Group, Other Cancer Meetings

March 29, 1985

Center Directors Urge NCI To Expand CTEP’s Treatment Referral Cntr.

March 12, 1993

Questionable 66 BCDDP Mastectomies Now Down To Three

February 17, 1978